230 related articles for article (PubMed ID: 11510233)
21. Experimental models of juvenile onset (insulin-dependent) diabetes mellitus.
Craighead JE
Monogr Pathol; 1980; 21():166-76. PubMed ID: 6261120
[No Abstract] [Full Text] [Related]
22. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.
Winer S; Tsui H; Lau A; Song A; Li X; Cheung RK; Sampson A; Afifiyan F; Elford A; Jackowski G; Becker DJ; Santamaria P; Ohashi P; Dosch HM
Nat Med; 2003 Feb; 9(2):198-205. PubMed ID: 12539039
[TBL] [Abstract][Full Text] [Related]
24. Death effectors of beta-cell apoptosis in type 1 diabetes.
Lee MS; Chang I; Kim S
Mol Genet Metab; 2004; 83(1-2):82-92. PubMed ID: 15464423
[TBL] [Abstract][Full Text] [Related]
25. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
26. Identification of key beta cell gene signaling pathways involved in type 1 diabetes.
Silva D; Petrovsky N
Ann N Y Acad Sci; 2004 Dec; 1037():203-7. PubMed ID: 15699518
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune versus inflammatory type I diabetes: a controversy?
Kolb H; Kolb-Bachofen V; Roep BO
Immunol Today; 1995 Apr; 16(4):170-2. PubMed ID: 7734042
[No Abstract] [Full Text] [Related]
28. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
29. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
30. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
Apostolou I; Von Boehmer H
J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
[No Abstract] [Full Text] [Related]
31. Role of cellular immunity in the pathogenesis of type I diabetes.
Gepts W
Curr Probl Clin Biochem; 1983; 12():86-107. PubMed ID: 6317288
[No Abstract] [Full Text] [Related]
32. [Molecular mechanisms of pancreatic beta-cell destruction in type 1 diabetes].
Isotani H; Hanafusa T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():383-7. PubMed ID: 12238077
[No Abstract] [Full Text] [Related]
33. [Transgenic mouse model of type 1 diabetes mellitus].
Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():70-4. PubMed ID: 12355837
[No Abstract] [Full Text] [Related]
34. Mechanisms of autoimmunity in insulin-dependent diabetes mellitus.
Bach JF
Clin Exp Immunol; 1988 Apr; 72(1):1-8. PubMed ID: 3293847
[No Abstract] [Full Text] [Related]
35. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
[TBL] [Abstract][Full Text] [Related]
36. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC
J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924
[TBL] [Abstract][Full Text] [Related]
37. The role of innate immunity in autoimmunity.
Bach JF; Bendelac A; Brenner MB; Cantor H; De Libero G; Kronenberg M; Lanier LL; Raulet DH; Shlomchik MJ; von Herrath MG
J Exp Med; 2004 Dec; 200(12):1527-31. PubMed ID: 15611284
[TBL] [Abstract][Full Text] [Related]
38. [The immunological aspects of the development of diabetes mellitus and its complications].
Kamaeva OI
Ter Arkh; 1994; 66(10):14-7. PubMed ID: 7863435
[No Abstract] [Full Text] [Related]
39. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM.
Corbett JA; McDaniel ML
Diabetes; 1992 Aug; 41(8):897-903. PubMed ID: 1378415
[TBL] [Abstract][Full Text] [Related]
40. [Type 1 and type 2 diabetes: clinical parallels].
Boitard C
Journ Annu Diabetol Hotel Dieu; 2004; ():1-10. PubMed ID: 15259300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
